Paclitaxel poliglumex (PPX)/carboplatin vs paclitaxel/carboplatin for the treatment of PS2 patients with chemotherapy-naive advanced non-small cell lung cancer (NSCLC): A phase III study.

被引：0
|
作者：
Langer, CJ
Socinski, MA
Ross, H
O'Byrne, KJ
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Oregon Clin, Portland, OR USA
[4] St James Hosp, Dublin 8, Ireland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1095S / 1095S
页数：1
相关论文
共 50 条
  • [1] XYOTAX™/carboplatin vs paclitaxel/carboplatin for the treatment of PS2 patients with chemotherapy-naive advanced non-small cell lung cancer (NSCLC):: The stellar 3 phase III study
    Langer, C
    O'Byrne, K
    Ross, H
    Socinski, M
    Szczesna, A
    Dediu, M
    Orlov, S
    Smakal, M
    LUNG CANCER, 2005, 49 : S36 - S36
  • [2] Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer
    Langer, Corey J.
    O'Byrne, Kenneth J.
    Socinski, Mark A.
    Mikhailov, Sergei M.
    Lesniewski-Kmak, Krzysztof
    Smakal, Martin
    Ciuleanu, Tudor E.
    Orlov, Sergey V.
    Dediu, Mircea
    Heigener, David
    Eisenfeld, Amy J.
    Sandalic, Larissa
    Oldham, Fred B.
    Singer, Jack W.
    Ross, Helen J.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : 623 - 630
  • [3] A randomized phase III trial comparing bexarotene/carboplatin/paclitaxel versus carboplatin/paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC).
    Blumenschein, GR
    Khuri, F
    Gatzemeier, U
    Miller, WH
    von Pawel, J
    Rigas, JR
    Herbst, RS
    Dziewanowska, Z
    Negro-Vilar, A
    Mabry, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 1094S - 1094S
  • [4] A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    Blumenschein, G
    Ludwig, C
    Thomas, G
    Tan, E
    Fanucchi, M
    Santoro, A
    Crawford, J
    Breton, J
    O'Brien, M
    Khuri, F
    LUNG CANCER, 2005, 49 : S30 - S30
  • [5] A phase III randomized trial of carboplatin/paclitaxel, with or without bexarotene (Targretin®), in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    Gatzemeier, U
    Blumenschein, G
    Jotte, R
    von Pawel, J
    Miller, W
    Khuri, F
    Rigas, J
    Mabry, M
    Dziewanowska, Z
    Negro-Vilar, A
    LUNG CANCER, 2005, 49 : S31 - S31
  • [6] Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II
    Blumenschein, George R., Jr.
    Khuri, Fadlo R.
    von Pawel, Joachim
    Gatzemeier, Ulrich
    Miller, Wilson H., Jr.
    Jotte, Robert M.
    Le Treut, Jacques
    Sun, Show-Li
    Zhang, Jinkun K.
    Dziewanowska, Zofia E.
    Negro-Vilar, Andres
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (11) : 1879 - 1885
  • [7] Safety and pharmacokinetic study of nab-paclitaxel plus carboplatin in chemotherapy-naive patients with advanced non-small cell lung cancer
    Okamoto, Isamu
    Yamamoto, Nobuyuki
    Kubota, Kaoru
    Ohe, Yuichiro
    Nogami, Naoyuki
    Murakami, Haruyasu
    Yamaya, Hidetoshi
    Ono, Katsuhiro
    Nakagawa, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1132 - 1137
  • [8] Paclitaxel poliglumex (PPX) in combination with carboplatin (carb) for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC): Preliminary data.
    Nemunaitis, JJ
    Leighl, N
    Miller, W
    Cormier, Y
    Bernareggi, A
    Oldham, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 677S - 677S
  • [9] Belinostat in Combination with Carboplatin and Paclitaxel in Patients with Chemotherapy-Naive Metastatic Lung Cancer (NSCLC)
    Waqar, Saiama
    Chawla, Sant
    Mathews, Brian
    Park, Dorothy
    Song, Tao
    Choi, Mi Rim
    Niederman, Thomas
    Govindan, Ramaswamy
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S888 - S889
  • [10] Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)
    Ono, Yasushi
    Hino, Mitsunori
    Ueda, Yuka
    Kamizuru, Ryoko
    Omata, Masatoshi
    Uehara, Takashi
    Tanaka, Yosuke
    Soma, Tomoyuki
    Kudoh, Shoji
    MEDICAL ONCOLOGY, 2007, 24 (04) : 402 - 406
12345